Trials / Conditions / Microsatellite Instability

Microsatellite Instability

18 registered clinical trials studyying Microsatellite Instability — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable GC/GEJC. NCT04817826	Gruppo Oncologico del Nord-Ovest	Phase 2
Unknown	Genetic Mutation in Epithelial Ovarian Cancer NCT04191252	Lei Li	—
Unknown	Genetic Mutation in Recurrent Cervical Cancer NCT04191226	Lei Li	—
Recruiting	Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers NCT03935893	Udai Kammula	Phase 2
Terminated	Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular I NCT04106167	Fate Therapeutics	—
Completed	Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome NCT05257057	WellSpan Health	—
Completed	FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumo NCT03841110	Fate Therapeutics	Phase 1
Completed	Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation NCT03519412	IFOM ETS - The AIRC Institute of Molecular Oncology	Phase 2
Active Not Recruiting	QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Im NCT03228667	ImmunityBio, Inc.	Phase 2
Unknown	MSI in Circulatory DNA of Endometrial Cancer NCT03744962	Lei Li	—
Terminated	Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients NCT03594448	University of Southern California	—
Terminated	Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer NCT03827044	Royal Marsden NHS Foundation Trust	Phase 3
Withdrawn	Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer NCT02966587	University of Washington	Phase 2
Unknown	Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Im NCT03447431	Assistance Publique - Hôpitaux de Paris	—
Completed	Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types NCT03012581	UNICANCER	Phase 2
Completed	APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors NCT03053466	Apollomics (Australia) Pty. Ltd.	Phase 1
Active Not Recruiting	National Cohort of Colorectal Cancers With Microsatellite Instability NCT05511688	Federation Francophone de Cancerologie Digestive	—
Completed	Molecular Characteristics of Early-onset Compared With Late-onset Colorectal Cancer NCT06238193	The First Affiliated Hospital with Nanjing Medical University	—